546,547 Olpasiran demonstrated a dose-dependent reduction in Lp(a) levels, with a single dose of 9 mg or higher reducing Lp(a) concentrations by over 90% for several months (NCT03626662)
After 60, several critical systems are in decline simultaneously: Growth hormone (GH) secretion drops significantly with age, reducing IGF-1 levels that govern muscle maintenance, fat metabolism, and tissue repair Insulin sensitivity worsens progressively, increasing metabolic syndrome risk Inflammatory signalling chronic low-grade inflammation ("inflammaging") accelerates cellular damage Sleep architecture slow-wave sleep decreases, impairing the overnight GH pulse that drives recovery Peptides that target the GH axis secretagogues like sermorelin, CJC-1295, and ipamorelin work by stimulating the pituitary to release more of your own growth hormone
What adverse effects are expected, and who manages them
Sinning A, Hubner CA
Our guide on how long GLP-1 takes to start working covers the typical onset timeline in detail
Most protocols call for four to eight weeks minimum
